|
| | 2,6-Dihydroxy-3-methylpurine Basic information |
| | 2,6-Dihydroxy-3-methylpurine Chemical Properties |
| Melting point | >300 °C (lit.) | | Boiling point | 294.33°C (rough estimate) | | density | 1.4434 (rough estimate) | | refractive index | 1.6700 (estimate) | | storage temp. | 2-8°C | | solubility | DMSO (Slightly, Heated), Methanol (Slightly) | | pka | pK1:8.10;pK2:11.3 (25°C) | | form | Solid | | color | White to Pale Beige | | Water Solubility | Insoluble in water. | | BRN | 180944 | | InChIKey | GMSNIKWWOQHZGF-UHFFFAOYSA-N | | CAS DataBase Reference | 1076-22-8(CAS DataBase Reference) |
| Hazard Codes | Xn,T+ | | Risk Statements | 22-26/27/28 | | Safety Statements | 22-24/25 | | WGK Germany | 1 | | RTECS | ZD8750000 | | HS Code | 29335990 | | Toxicity | LD50 intraperitoneal in mouse: 894mg/kg |
| | 2,6-Dihydroxy-3-methylpurine Usage And Synthesis |
| Chemical Properties | Light yellow powder | | Uses | 3-Methylxanthine is a Xanthine derivative with diuretic, cardiac stimulant and smooth muscle relaxant activities; isomeric with theobromine.They can also act as Bronchodilator. | | Definition | ChEBI: 3-methyl-9H-xanthine is a 3-methylxanthine tautomer where the imidazole proton is located at the 9-position. It has a role as a metabolite. It is a tautomer of a 3-methyl-7H-xanthine. | | General Description | 3-Methylxanthine, a metabolite of theophylline, was quantitated in rat plasma by a sensitive LC-MS/MS method. | | Purification Methods | Crystallise it from water. [Beilstein 26 II 263, 26 III/IV 2329.] |
| | 2,6-Dihydroxy-3-methylpurine Preparation Products And Raw materials |
|
